Journey Medical Corp (DERM) has issued an announcement.
Journey Medical Corporation has solidified its executive team by promoting Joseph Benesch to permanent Chief Financial Officer, effective April 26, 2024. Benesch had been serving as the interim CFO since January 27, 2023, and this transition comes without any immediate change to his compensation. The appointment reflects the company’s confidence in his abilities, as there are no disclosed family ties or material interests influencing the decision. This strategic move was publicly announced via a press release on May 1, 2024.
See more insights into DERM stock on TipRanks’ Stock Analysis page.
